News

  • Toxins and climate harms having ‘alarming’ effect on fertility, research warns

    Simultaneous exposure to toxic chemicals and climate-related heat may be worsening fertility harms across humans and wildlife, research suggests. The review of scientific literature looks at how endocrine-disrupting chemicals, often found in plastic, together with climate-related effects such as heat stress, are each linked to lower fertility and fecundity, meaning the ability to reproduce, across [...]

  • Home blood pressure checks could lower heart risks for new mothers – study

    Home blood pressure checks after hypertensive pregnancy could cut the risk of heart attack, stroke and potentially early death, research suggests. Women who regularly monitored their blood pressure in the weeks after giving birth, and had doctors tailor their medication if needed, had better functioning arteries nine months later than those who received routine care. [...]

  • Researcher explores weight loss jab impact on PCOS

    Weight loss jabs are being studied to see if they could help women with polycystic ovary syndrome (PCOS) The condition, which affects up to one in ten women, changes how the ovaries work and is linked to infertility and weight gain. Dr Shagaf Bakour has won a £60,000 NHS research grant through Sandwell and West [...]

  • Researchers teach AI to spot cancer risk by squeezing individual breast cells

    An AI tool could help spot breast cancer risk by analysing how individual breast cells behave when squeezed under stress, research suggests. Researchers at City of Hope and the University of California, Berkeley, created a microfluidic platform that assesses women’s breast cancer risk at the cellular level. The platform squeezes individual breast epithelial cells, which [...]

  • Experimental drug drowns triple-negative breast cancer cells in toxic fats

    An experimental drug slowed triple-negative breast cancer in mice by flooding tumour cells with toxic fats. Triple-negative breast cancer lacks three common drug targets, making it one of the hardest-to-treat and most aggressive forms of the disease. The compound, known as DH20931, appears to push cancer cells past their limits by triggering a surge in [...]

  • Future Fertility raises Series A financing to scale AI tools redefining fertility care worldwide

    Future Fertility Inc. has announced the closing of a US$4.1 million Series A financing round. The round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany) and Whitecap Venture Partners, with participation from new investors Sandpiper Ventures, Gaingels, and Jolt VC. The financing will accelerate Future Fertility's commercial expansion [...]

  • HRT maker censured by regulators for ‘systemic failures’ that risked patient safety

    Theramex has been censured over HRT failures that regulators said jeopardised patient safety. The UK producer of HRT drugs, including Evorel and Intrarosa, was found to have breached fundamental compliance standards. These included not updating crucial prescribing information, in some cases for several years, and not making clear that one drug must not be used [...]

  • Women’s HealthX confirms exceptional speaker line-up to advance fertility and reproductive care

    By Women’s HealthX Women's HealthX has confirmed an outstanding cohort of fertility and reproductive care leaders for its upcoming event, bringing together the senior clinicians, medical directors, and innovators shaping evidence-based practice across hospitals and healthcare systems globally. Timed to coincide with Infertility Awareness Week, this announcement underscores the event's commitment to accelerating the adoption [...]

  • Elimination of cervical cancer in EU an ‘achievable goal’, report finds

    Cervical cancer elimination in the EU is becoming achievable as HPV vaccination coverage rises, a new report says. As Europe marks European Immunisation Week 2026, the European Centre for Disease Prevention and Control said progress in human papillomavirus vaccination is continuing across the EU and European Economic Area. All EU and European Economic Area countries [...]

  • More than half of women with gestational diabetes face harmful stigma, research reveals

    More than half of women with gestational diabetes report stigma from healthcare staff, family, friends and wider society, new research shows. A survey of 1,800 UK women found widespread emotional distress at diagnosis of the condition, a form of high blood sugar that develops during pregnancy, with effects lasting beyond birth. Gestational diabetes affects around [...]